Company news
Tetra Bio-Pharma Inc. news in 2021
Tetra Bio-Pharma Inc.'s news releases, calls and decks from 2021, newest first.
Tetra Bio-Pharma Announces Closing of $2.1 Million Marketed Public Offering of Units
December 21, 2021
Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units
December 14, 2021
CEOs Presenting at the Emerging Growth Conference on December 8; Register Now
December 7, 2021
Tetra Bio-Pharma Announces Up To $13.0 Million Marketed Public Offering of Units
December 1, 2021
QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols
November 29, 2021
Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™
November 29, 2021
Tetra Bio-Pharma Inc. Announces Termination of "At-The-Market" Offering
November 4, 2021
DGAP-News: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF(TM) from the European Medicines Agency
October 20, 2021
Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF™ from the European Medicines Agency
October 21, 2021
DGAP-News: Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)
October 13, 2021
Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF™
October 14, 2021
REDUVO™ - A Major Milestone for Tetra Bio-Pharma Inc.
October 5, 2021
Tetra Bio-Pharma Receives Positive Scientific Advice Assessment (SAA) Report for QIXLEEF™
September 2, 2021
Tetra Bio-Pharma Files PCT Patent Application for Cannabis Plant Residue
July 29, 2021
Tetra Bio-Pharma Engages Christine Caron as Patient Partner
July 22, 2021
Tetra Bio-Pharma Accelerates REBORN1© Trial
July 12, 2021
Tetra Bio-Pharma Announces Change in Management
June 25, 2021
Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma's Innovative Drug ARDS-003
June 21, 2021
Next Super Stocks on the Move: Tetra Bio-Pharma, Red Light Holland, FansUnite, and Skylight Health
June 11, 2021
Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
June 1, 2021
Tetra Bio-Pharma Announces Voting Results of 2021 Annual General and Special Meeting
May 28, 2021
Tetra Bio-Pharma Announces Clinical Advancements and Establishment of At-the-Market Equity Program
May 28, 2021
Tetra Bio-Pharma Announces Exercise of Over-Allotment Option in Connection with Bought Deal Financing
May 21, 2021
Tetra Bio-Pharma Inc. Announces Changes to its Board of Directors and the Filing of a Supplement to its Management Information Circular
May 18, 2021
Tetra Bio-Pharma Announces Closing of Bought Deal Offering
May 17, 2021
NEXT SUPER STOCKS on The Move: FansUnite, Reliq Health Tech, Hapbee, and Tetra Bio-Pharma
May 12, 2021
Tetra Bio-Pharma Accelerates PLENITUDE(C) Clinical Trial to Evaluate the Effect of Cannabis for Use in Managing Uncontrolled Cancer Pain
May 10, 2021
Tetra Bio-Pharma Announces $10 Million "Bought Deal" Public Offering
May 10, 2021
NEXT SUPER STOCKS on The Move: Tetra Bio-Pharma, Relay Medical, Victory Square Technologies, and Red Light Holland
May 7, 2021
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial
May 5, 2021
Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios
May 4, 2021
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
May 2, 2021
Next Super Stocks on The Move: Tetra Bio-Pharma, ESE Entertainment, Red Light Holland, and Skylight Health. Innovation Leaders in E-Sports, Healthcare, Psychedelics, and Pharma Targeting Billion Dollar Markets.
April 29, 2021
Tetra Bio-Pharma Submits Request for Scientific Advice to Malta Medicines Authority
April 27, 2021
Tetra Bio-Pharma Provides an Update on its U.S. REBORN1 Clinical Trial
April 22, 2021
Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis
April 14, 2021
Tetra Bio-Pharma Provides Update on Its New Drug Submission Application in Canada
April 13, 2021
NEXT SUPER STOCKS Addressing Multi-Billion Dollar Healthcare Markets: Tetra Bio-Pharma, Relay Medical, Skylight Health, Reliq HealthTech
March 31, 2021
Tetra Bio-Pharma Inc. Announces $10 Million Bought Deal Offering of Units
February 22, 2021
Tetra Bio-Pharma Inc. Announces Closing of Non-Brokered Private Placement
February 3, 2021
Tetra Bio-Pharma Inc. Announces a Non-Brokered Private Placement
January 27, 2021